Your browser doesn't support javascript.
loading
Combined chemoradiotherapy with gemcitabine in patients with locally advanced inoperable transitional cell carcinoma of the urinary bladder and/or in patients ineligible for surgery: a phase I trial.
De Santis, M; Bachner, M; Cerveny, M; Kametriser, G; Steininger, T; Königsberg, R; Schratter-Sehn, A; Sedlmayer, F; Dittrich, C.
Afiliación
  • De Santis M; Ludwig Boltzmann Institute for Applied Cancer Research (LBI-ACR VIEnna)-LB Cluster Translational Oncology (LB-CTO), Kaiser Franz Josef-Spital, Vienna; Applied Cancer Research-Institution for Translational Research Vienna (ACR-ITR VIEnna)/CEADDP, Vienna. Electronic address: maria.desantis@wienkav.at.
  • Bachner M; Ludwig Boltzmann Institute for Applied Cancer Research (LBI-ACR VIEnna)-LB Cluster Translational Oncology (LB-CTO), Kaiser Franz Josef-Spital, Vienna; Applied Cancer Research-Institution for Translational Research Vienna (ACR-ITR VIEnna)/CEADDP, Vienna.
  • Cerveny M; Institute for Radiooncology, KFJ-Hospital, Vienna.
  • Kametriser G; Department for Radiotherapy and Radio-Oncology, Landeskrankenhaus Salzburg, Paracelsus Medical University Clinics, Salzburg, Austria.
  • Steininger T; Ludwig Boltzmann Institute for Applied Cancer Research (LBI-ACR VIEnna)-LB Cluster Translational Oncology (LB-CTO), Kaiser Franz Josef-Spital, Vienna; Applied Cancer Research-Institution for Translational Research Vienna (ACR-ITR VIEnna)/CEADDP, Vienna.
  • Königsberg R; Ludwig Boltzmann Institute for Applied Cancer Research (LBI-ACR VIEnna)-LB Cluster Translational Oncology (LB-CTO), Kaiser Franz Josef-Spital, Vienna; Applied Cancer Research-Institution for Translational Research Vienna (ACR-ITR VIEnna)/CEADDP, Vienna.
  • Schratter-Sehn A; Institute for Radiooncology, KFJ-Hospital, Vienna.
  • Sedlmayer F; Department for Radiotherapy and Radio-Oncology, Landeskrankenhaus Salzburg, Paracelsus Medical University Clinics, Salzburg, Austria.
  • Dittrich C; Ludwig Boltzmann Institute for Applied Cancer Research (LBI-ACR VIEnna)-LB Cluster Translational Oncology (LB-CTO), Kaiser Franz Josef-Spital, Vienna; Applied Cancer Research-Institution for Translational Research Vienna (ACR-ITR VIEnna)/CEADDP, Vienna.
Ann Oncol ; 25(9): 1789-1794, 2014 Sep.
Article en En | MEDLINE | ID: mdl-24936582
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Dosis Máxima Tolerada Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Dosis Máxima Tolerada Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article